A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
Clinical trial NCT03160430 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT03160430
- Sponsor
- Resverlogix Corp
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-22
- Primary completion
- 2026-11-22
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.